Total Payments
$6,500
2024 Payments
$1,298
Companies
23
Transactions
212
Medicare Patients
461
Medicare Billing
$43,873
Payment Breakdown by Category
Food & Beverage$5,849 (90.0%)
Education$651.12 (10.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,849 | 201 | 90.0% |
| Education | $651.12 | 11 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $1,295 | 43 | $0 (2024) |
| Gilead Sciences, Inc. | $1,022 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $834.05 | 25 | $0 (2023) |
| Janssen Products, LP | $764.58 | 9 | $0 (2023) |
| ABBVIE INC. | $725.12 | 29 | $0 (2024) |
| Shionogi Inc | $319.31 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $265.58 | 9 | $0 (2024) |
| Allergan, Inc. | $238.63 | 8 | $0 (2020) |
| Melinta Therapeutics, LLC | $207.19 | 9 | $0 (2024) |
| Insmed, Inc. | $204.68 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,298 | 46 | ViiV Healthcare Company ($451.40) |
| 2023 | $1,350 | 48 | Janssen Biotech, Inc. ($396.89) |
| 2022 | $727.33 | 30 | ABBVIE INC. ($310.38) |
| 2021 | $762.72 | 25 | AbbVie Inc. ($175.38) |
| 2020 | $694.55 | 17 | Janssen Biotech, Inc. ($161.37) |
| 2019 | $719.09 | 29 | Allergan Inc. ($167.01) |
| 2018 | $279.83 | 7 | Janssen Products, LP ($169.61) |
| 2017 | $668.36 | 10 | ViiV Healthcare Company ($360.00) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 2 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: HIV | ||||||
| 05/02/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: HIV | ||||||
| 05/01/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: HIV | ||||||
| 05/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.67 | General |
| 04/24/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/17/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: HIV | ||||||
| 03/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.62 | General |
| 03/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.03 | General |
| 03/25/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: HIV | ||||||
| 03/23/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: HIV | ||||||
| 03/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.01 | General |
| 03/13/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: HIV | ||||||
| 03/07/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.57 | General |
| 02/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.18 | General |
| 02/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.38 | General |
| 01/22/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: HIV | ||||||
| 01/20/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.29 | General |
| 01/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.25 | General |
| 01/10/2024 | Shionogi Inc | Fetroja (Drug) | Education | In-kind items and services | $1.47 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/19/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: VIROLOGY | ||||||
| 12/18/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: HIV | ||||||
| 12/17/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: HIV | ||||||
| 12/15/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.84 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 77 | 118 | $24,100 | $7,239 |
| 2022 | 5 | 132 | 186 | $37,285 | $12,420 |
| 2021 | 4 | 119 | 164 | $32,990 | $11,561 |
| 2020 | 4 | 133 | 187 | $38,175 | $12,653 |
Total Patients
461
Total Services
655
Medicare Billing
$43,873
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 72 | $12,600 | $3,620 | 28.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 26 | 28 | $7,000 | $2,175 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 18 | $4,500 | $1,444 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 83 | $14,525 | $4,242 | 29.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 40 | 41 | $10,250 | $4,021 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 23 | $5,750 | $1,780 | 31.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 26 | $4,420 | $1,744 | 39.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 13 | $2,340 | $632.84 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 78 | $13,650 | $4,231 | 31.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 37 | 38 | $9,500 | $3,760 | 39.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 27 | $4,590 | $1,847 | 40.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 21 | $5,250 | $1,724 | 32.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 58 | 61 | $15,250 | $5,950 | 39.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 50 | $8,500 | $3,411 | 40.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 61 | $10,675 | $2,463 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 15 | $3,750 | $829.01 | 22.1% |
About Dr. Olga Badem, MD
Dr. Olga Badem, MD is a Infectious Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295704963.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Olga Badem, MD has received a total of $6,500 in payments from pharmaceutical and medical device companies, with $1,298 received in 2024. These payments were reported across 212 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,849).
As a Medicare-enrolled provider, Badem has provided services to 461 Medicare beneficiaries, totaling 655 services with total Medicare billing of $43,873. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Brooklyn, NY
- Active Since 03/16/2006
- Last Updated 11/02/2017
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1295704963
Products in Payments
- SYMTUZA (Drug) $1,100
- DOVATO (Drug) $648.54
- MAVYRET (Drug) $482.76
- PREZCOBIX (Drug) $328.60
- Fetroja (Drug) $319.31
- XARELTO (Drug) $265.58
- AVYCAZ (Drug) $230.95
- Symtuza (Drug) $202.41
- Arikayce (Drug) $188.44
- DALVANCE (Drug) $134.13
- Vabomere (Drug) $129.56
- Descovy (Drug) $125.00
- Truvada (Drug) $125.00
- RUKOBIA (Drug) $120.61
- CABENUVA (Biological) $101.46
- GATTEX (Drug) $73.74
- SEROSTIM (Drug) $67.56
- APRETUDE (Biological) $64.56
- Cologuard Collection Kit (Device) $62.39
- TEFLARO (Drug) $58.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Brooklyn
Andre Brutus
Infectious Disease — Payments: $379,075
Infectious Disease $379,075
Dr. Joseph Paul, M.d, M.D
Infectious Disease — Payments: $294,392
Infectious Disease $294,392
Marcus Sandling
Infectious Disease — Payments: $69,398
Infectious Disease $69,398
Dr. Jessica Yager, M.d, M.D
Infectious Disease — Payments: $46,298
Infectious Disease $46,298
Yusuf Afacan, M.d, M.D
Infectious Disease — Payments: $27,239
Infectious Disease $27,239
Dr. Jacquelyn Lahoud, M.d, M.D
Infectious Disease — Payments: $9,095
Infectious Disease $9,095